Zimmer inks ceramic deal
This article was originally published in The Gray Sheet
Executive Summary
PMA application for firm's ceramic-on-ceramic Trilogy AB hip will be filed by year-end, following a pact with German component supplier CeramTec, announced Oct. 15. The ceramic hips have been available in Europe under Zimmer's acquired Centerpulse business. Zimmer anticipates U.S. approval in the second half of 2005. The orthopedics manufacturer joins Smith & Nephew as a ceramic hip developer and will compete against FDA-approved products from Stryker and Wright Medical (1"The Gray Sheet" Feb. 16, 2004, p. 9)...
You may also be interested in...
Zimmer Integration Effort “Ahead Of Schedule,” Will Cost $79 Mil. In 2004
Zimmer hopes to further differentiate its total knee replacement offerings with the formal launch of its MIS Quad-Sparing minimally-invasive implant procedure at the American Academy of Orthopedic Surgeons meeting March 10-14 in San Francisco
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.